Search

Your search keyword '"Visentin, Andrea"' showing total 749 results

Search Constraints

Start Over You searched for: Author "Visentin, Andrea" Remove constraint Author: "Visentin, Andrea"
749 results on '"Visentin, Andrea"'

Search Results

1. Optimizing Quantile-based Trading Strategies in Electricity Arbitrage

2. Outcomes in high-risk subgroups after fixed-duration ibrutinib + venetoclax for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL): Up to 5.5 years of follow-up in the phase 2 CAPTIVATE study.

3. Electricity Price Forecasting in the Irish Balancing Market

6. Forecasting Workload in Cloud Computing: Towards Uncertainty-Aware Predictions and Transfer Learning

7. Explainable Algorithm Selection for the Capacitated Lot Sizing Problem

8. Clustering-Based Numerosity Reduction for Cloud Workload Forecasting

11. SATfeatPy -- A Python-based Feature Extraction System for Satisfiability

14. Stochastic Dynamic Programming Heuristic for the (R, s, S) Policy Parameters Computation

16. Leukemic cell-secreted interleukin-9 suppresses cytotoxic T cell-mediated killing in chronic lymphocytic leukemia

19. Computing Optimal (R, s, S) Policy Parameters by a Hybrid of Branch-and-Bound and Stochastic Dynamic Programming

21. Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY

23. Combating inequalities: what role for universal social protection?

25. Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL

27. Baseline prognostic predictors in classical Hodgkin Lymphoma: a retrospective, single-center analysis on patients treated with PET/CT-guided ABVD.

28. Focal adhesion kinase as a new player in the biology of oncohematological diseases: the starting evidence.

30. COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

31. Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapy

32. A rescue approach in refractory diffuse large B-cell lymphoma with obinutuzumab-redirected cytokine-induced killer cells: a first-in-human case report

33. Exploring the prognostic role of complex karyotype in chronic lymphocytic leukaemia patients treated with venetoclax‐based regimens

35. Efficacy and safety of venetoclax plus hypomethylating agents in relapsed/refractory acute myeloid leukemia: a multicenter real-life experience

36. When Waldenström macroglobulinemia hits the kidney: Description of a case series and management of a “rare in rare” scenario

38. Impact of the presence and number of chromosomal abnormalities on the clinical outcome in Waldenström Macroglobulinemia: a monocentric experience

39. Modelling Dynamic Programming-Based Global Constraints in Constraint Programming

42. Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study

43. Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL

44. AI-Based Task Classification With Pressure Insoles for Occupational Safety

45. Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study

47. CD49d expression is included in a revised 4‐factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real‐world experience.

49. p66Shc deficiency in CLL cells enhances PD-L1 expression and suppresses immune synapse formation

Catalog

Books, media, physical & digital resources